Aurobindo Pharma Ltd — Cephalexin Exporter Profile
Indian Pharmaceutical Exporter · #3 for Cephalexin · $11.8M export value · DGFT Verified
Aurobindo Pharma Ltd is the #3 Indian exporter of Cephalexin with $11.8M in export value and 242 verified shipments. Aurobindo Pharma Ltd holds a 4.6% market share in Cephalexin exports across 5 countries.
Aurobindo Pharma Ltd — Cephalexin Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Cephalexin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.0M | 186 | 66.4% |
| CANADA | $1.5M | 62 | 16.8% |
| UNITED KINGDOM | $652.6K | 56 | 7.2% |
| ETHIOPIA | $427.1K | 12 | 4.7% |
| UNITED STATES OF AMERICA | $329.7K | 9 | 3.6% |
| SOUTH AFRICA | $116.1K | 5 | 1.3% |
Aurobindo Pharma Ltd exports Cephalexin to 6 countries. The largest destination is UNITED STATES accounting for 66.4% of Aurobindo Pharma Ltd's Cephalexin shipments, followed by CANADA (16.8%) and UNITED KINGDOM (7.2%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cephalexin from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CRONUS PHARMA LLC, | UNITED STATES | $1.2M | 31 |
| SIVEM PHARMACEUTICALS | UNITED STATES | $971.9K | 28 |
| CRONUS PHARMA LLC | UNITED STATES | $964.0K | 29 |
| AURO PHARMA INC, | CANADA | $601.5K | 26 |
| AUROBINDO PHARMA USA INC | UNITED STATES OF AMERICA | $565.7K | 14 |
| MILPHARM LIMITED | UNITED KINGDOM | $506.4K | 45 |
| AUROBINDO PHARMA USA., INC, | UNITED STATES | $503.3K | 17 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $456.0K | 16 |
| AURO PHARMA INC | CANADA | $427.1K | 22 |
| AUROLOGISTICS LLC | UNITED STATES | $400.0K | 8 |
Aurobindo Pharma Ltd supplies Cephalexin to 37 buyers globally. The largest buyer is CRONUS PHARMA LLC, (UNITED STATES), followed by SIVEM PHARMACEUTICALS (UNITED STATES) and CRONUS PHARMA LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cephalexin Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $108.9M worth of Cephalexin through 5,117 shipments from 223 suppliers to 104 countries, serving 516 buyers globally. Aurobindo Pharma Ltd contributes $11.8M to this total, accounting for 4.6% of India's Cephalexin exports. Aurobindo Pharma Ltd ships Cephalexin to 6 countries through 37 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Cephalexin Exports?
Aurobindo Pharma Ltd's average Cephalexin shipment value is $48.7K per consignment, based on 242 shipments totaling $11.8M. The largest destination is UNITED STATES (66.4% of Aurobindo Pharma Ltd's Cephalexin exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Cephalexin Exporters?
Aurobindo Pharma Ltd ranks #3 among 223 Indian Cephalexin exporters with a 4.6% market share. The top 3 exporters are ALKEM LABORATORIES LIMITED ($30.9M), LUPIN LIMITED ($30.1M), AUROBINDO PHARMA LTD ($11.8M). Aurobindo Pharma Ltd processed 242 shipments to 5 destination countries.
What Cephalexin Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) | $384.3K | 15 |
| CEPHALEXIN TABLETS 500 MG (AURO-CEPHALEX | $377.5K | 9 |
| CEFALEXIN TABLETS BP 500MG (CEPHALEXIN T | $231.5K | 6 |
| CEPHALEXIN CAPSULES 500MG (Aurocef 500 ( | $230.3K | 5 |
| CEPHALEXIN CAPSULES 500MG (Cephalexin Ca | $207.2K | 7 |
| CEPHALEXIN CAPSULES 500MG CEPHALEXIN CAPSULES USP 500 MG | $200.0K | 4 |
| CEPHALEXIN CAPSULES 250MG (Cephalexin Capsules USP 250 mg) | $195.5K | 6 |
| CEPHALEXIN TABLETS 500 MG(AURO-CEPHALEXI | $164.0K | 4 |
| CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CA | $158.5K | 7 |
| CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) (6941 X 500'S PACKS =3470500 NOS)NOS | $150.0K | 3 |
Aurobindo Pharma Ltd exports 194 distinct Cephalexin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) with 15 shipments worth $384.3K.
Regulatory Requirements: Exporting Cephalexin to Key Markets
What Aurobindo Pharma Ltd must comply with to export Cephalexin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Cephalexin Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LIMITED | $30.9M | 618 | 3 | $50.0K |
| 2 | LUPIN LIMITED | $30.1M | 601 | 7 | $50.0K |
| 3 | AUROBINDO PHARMA LTD ★ | $11.8M | 242 | 5 | $48.7K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $10.6M | 294 | 10 | $36.1K |
| 5 | CIPLA LIMITED | $9.2M | 184 | 3 | $50.0K |
Aurobindo Pharma Ltd ranks #3 among 223 Indian Cephalexin exporters. Average shipment value of $48.7K compared to the market average of $488.4K. The closest competitors by value are ALKEM LABORATORIES LIMITED and LUPIN LIMITED.
Which Indian Ports Ship Cephalexin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 873 | 17.1% |
| SAHAR AIR | 744 | 14.5% |
| DELHI AIR CARGO ACC (INDEL4) | 538 | 10.5% |
| NHAVA SHEVA SEA (INNSA1) | 398 | 7.8% |
| DELHI AIR | 340 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 275 | 5.4% |
| JNPT | 220 | 4.3% |
| Bombay Air | 163 | 3.2% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cephalexin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cephalexin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 330 individual customs records matching Aurobindo Pharma Ltd exporting Cephalexin, covering 194 formulations to 6 countries via 37 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cephalexin Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Cephalexin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Cephalexin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cephalexin. For current shipment-level data, contact TransData Nexus.